LEGN
Legend Biotech Corp Earnings
$33.1
Earnings Summary
Revenue | $255.95Mn |
Net Profits | $-125.82Mn |
Net Profit Margins | -49.16% |
Legend Biotech Corp’s revenue jumped 37.22% since last year same period to $255.95Mn in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated 31.22% jump in its revenue since last 3-months.
Legend Biotech Corp’s net profit fell -591.47% since last year same period to $-125.82Mn in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated -24.68% fall in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin fell -403.9% since last year same period to -49.16% in the Q2 2025. On a quarterly growth basis, Legend Biotech Corp has generated 4.99% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Current Year | -0.03 |
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.03 - a 70.92% jump from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.03.
Key Ratios
Earning Per Share (EPS) | 0 |
Legend Biotech Corp’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Legend Biotech Corp has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-24 | -0.03 | 0 | 100% |
2025-05-13 | -0.25 | -0.54 | -112.6% |
2025-08-11 | -0.12 | 0.03 | 125% |
